5 Division of Hospital Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA Correspondence: Rakesh Kumar, Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA, 55905, Email [email protected] Abstract: Acetyl-l-carnitine (ALC) is increasingly recognized for its potential psychopharmacological mechanism and role in the treatment of mood disorders, particularly major depressive disorder (MDD) and bipolar disorder (BD)
weakest in Authenticity (2.7/5) and Trust & Transparency (3.5/5)
Early research and growing examples suggest that addressing both hormonal decline with MHT and metabolic changes with GLP-1 therapy could result in greater weight loss and metabolic improvements compared to either approach alone
The honest evidence tier for sermorelin is therefore human, but older and narrow, with the further complication that the material available today is not the FDA-approved product those older studies used